“Although macroeconomic factors can dominate market trends, we believe that earnings are the primary driver of share prices, especially for underperforming small-cap stocks in the short term,” Raymond said.

“We anticipate that the release of trading updates and possible financial year 2025 guidance during the AGM season could significantly impact price movements for many companies.

“We’re particularly interested in CSL’s R&D Investor Day on October 22nd, which could serve as a positive catalyst for the company.

“This event will provide an opportunity to explore emerging therapies and gain insights into competitive dynamics,” Raymond added.

GRAPH FOR CSL

Important: This content has been prepared without taking account of the objectives, financial situation or needs of any particular individual. It does not constitute formal advice. Consider the appropriateness of the information in regard to your circumstances.